Julienas, France

Gersande R Lena

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2010-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gersande R Lena: Innovator in Diabetes Treatment

Introduction

Gersande R Lena is a notable inventor based in Julienas, France. He has made significant contributions to the field of diabetes treatment through his innovative research and development of pharmaceutical compounds. With a total of three patents to his name, Lena's work focuses on creating effective solutions for managing diabetes and its associated complications.

Latest Patents

Lena's latest patents include groundbreaking inventions aimed at improving diabetes treatment. One of his notable patents is for "Useful thiophene derivatives in the treatment of diabetes." This invention relates to a thiophene derivative that can be used as a drug for treating and preventing diabetes, particularly type II diabetes and hyperglycemia. Another significant patent is for "Imidazopyridine derivatives useful in treating diabetes." This invention involves imidazopyridine derivatives that serve as drugs for treating and preventing diabetes and its complications.

Career Highlights

Throughout his career, Gersande R Lena has worked with esteemed organizations such as Metabrain Research and the Centre National De La Recherche Scientifique. His work in these institutions has allowed him to advance his research and contribute to the scientific community's understanding of diabetes treatment.

Collaborations

Lena has collaborated with notable colleagues, including Franck F Lepifre and Valerie Autier. These partnerships have further enriched his research and development efforts in the field of diabetes.

Conclusion

Gersande R Lena's innovative work in developing new treatments for diabetes showcases his dedication to improving patient outcomes. His patents reflect a commitment to addressing the challenges posed by this chronic condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…